Atlas of Genetics and Cytogenetics in Oncology and Haematology
Home
Genes
Leukemias
Solid Tumors
Cancer-Prone
Deep Insight
Case Reports
Journals
Portal
Teaching
X
Y
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
NA
International Classification of Diseases (ICD-O-3]
Morphological codes
980 Leukemias
[ Previous ]
[ Next ]
Main Menu
9800/3
Leukemia, NOS
Subacute leukemia, NOS [obs]
Chronic leukemia, NOS [obs]
Aleukemic leukemia, NOS [obs]
9801/3
Acute leukemia, NOS
TBL1XR1/MECOM fusion::del(3)(q26.2q26.3) TBL1XR1/MECOM
Mixed phenotype acute leukemia (MPAL)
-20 or monosomy 20
+X solely in myeloid malignancies
der(2)t(1;2)(q12-21;q37)
der(4)t(1;4)(q11-32;q34-35)
Blast cell leukemia
Stem cell leukemia
Undifferentiated leukaemia
9805/3
Acute biphenotypic leukemia
Biphenotypic Acute Leukaemia (BAL)
i(5)(p10) in hematological malignancies
-20 or monosomy 20
Acute mixed lineage leukemia
Acute bilineal leukemia
9806/3
Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1
Mixed phenotype acute leukemia (MPAL)
t(9;22)(q34;q11) BCR/ABL1 in ALL
9807/3
Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged
del(11)(q23q23) KMT2A/CBL::t(11;11)(q23;q23) KMT2A/CBL
del(11)(q23q23) KMT2A/ARHGEF12
ins(5;11)(q31;q13q23) KMT2A/AFF4
Mixed phenotype acute leukemia (MPAL)
t(1;11)(p32;q23) KMT2A/EPS15
t(2;11)(p21;q23) KMT2A/?
t(2;11)(q11;q23) KMT2A/AFF3
t(2;11)(q37;q23) KMT2A/SEPT2
t(3;11)(p21;q23) KMT2A/NCKIPSD
t(3;11)(q21;q23) KMT2A/EEFSEC
t(3;11)(q28;q23) KMT2A/LPP
t(4;11)(q21;q23) KMT2A/AFF1
t(4;11)(q35;q23) KMT2A/SORBS2
t(5;11)(q31;q23) KMT2A/ARHGAP26
t(6;11)(q27;q23) KMT2A/AFDN
t(6;11)(q13;q23) KMT2A/SMAP1
t(6;11)(q15;q23) KMT2A/?
t(9;11)(q34;q23) FNBP1/KMT2A
t(9;11)(q34;q23) KMT2A/DAB2IP
t(X;11)(q13;q23) KMT2A/FOXO4
t(X;11)(q22;q23) KMT2A/?
t(X;11)(q24;q23) KMT2A/SEPT6
t(10;11)(p12;q23) KMT2A/MLLT10
t(10;11)(p11.2;q23) KMT2A/ABI1
t(10;11)(q22;q23) KMT2A/TET1
t(11;11)(q13;q23) KMT2A/ARHGEF17
t(11;11)(q14;q23) KMT2A/PICALM::inv(11)(q14q23) KMT2A/PICALM
t(11;14)(q23;q32) KMT2A/CEP170B
t(11;15)(q23;q14) KMT2A/CASC5
t(11;15)(q23;q14) KMT2A/ZFYVE19
t(11;16)(q23;p13.3) KMT2A/CREBBP
t(11;17)(q23;q25) KMT2A/SEPT9
t(11;17)(q23;p13) KMT2A/GAS7
t(11;17)(q23;q12) KMT2A/RARA
t(11;17)(q23;q12-21) KMT2A/MLLT6
t(11;17)(q23;q12-21) KMT2A/LASP1
t(11;19)(q23;p13.1) KMT2A/ELL
t(11;19)(q23;p13.3) KMT2A/MLLT1
t(11;19)(q23;p13) KMT2A/SH3GL1
t(1;11)(q21;q23) KMT2A/MLLT11
t(11;20)(q23;q11) KMT2A/MAPRE1
t(11;22)(q23;q11.2) KMT2A/SEPT5
t(11;22)(q23;q13) KMT2A/EP300
11q23 rearrangements (KMT2A) in childhood acute lymphoblastic leukemia
11q23 rearrangements (KMT2A) in de novo childhood acute myeloid leukemia
11q23 rearrangements (KMT2A) in leukaemia
11q23 rearrangements (KMT2A) in therapy related leukaemias
9808/3
Mixed phenotype acute leukemia, B/myeloid, NOS
der(5)t(1;5)(q12-q25;q13-q35)
dic(7;12)(p10-p12;p11-p13)
i(8)(q10) in ALL
Mixed phenotype acute leukemia (MPAL)
+X solely in myeloid malignancies
t(7;14)(p15;q32)
t(14;19)(q32;q13) IGH/Various Partners
9809/3
Mixed phenotype acute leukemia, T/myeloid, NOS
Mixed phenotype acute leukemia (MPAL)
Home
Genes
Leukemias
Solid Tumors
Cancer-Prone
Deep Insight
Case Reports
Journals
Portal
Teaching
X
Y
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
NA